I think he didn't want to address the LymPro revenue guidance issue. Jason has just publicly said a week before that he estimated Lympro's 2015 revenue to be 1 million dollars. I was frustrated that neither Jason nor Gerald talked about 2015 Lympro revenues.
That's why I assumed he limited the shareholder questions to one.
(0)
(0)
Amarantus Bioscience Holdings (AMBS) Stock Research Links